Mo Alavijeh, Managing Director at Pharmidex, is excited to be attending the ELRIG UK Drug Discovery 2024 meeting!
October 3, 2024
I’m thrilled to be here at the
ERLIG Drug Discovery 2024 (https://elrig.org/portfolio/drug-discovery-2024/) meeting, surrounded by so many talented professionals and innovators in the drug discovery field.
It's always inspiring to connect with colleagues who share the same passion for pushing the boundaries of science and improving patient outcomes.
Looking forward to insightful discussions, new collaborations, and exploring the latest breakthroughs that will shape the future of drug discovery!
If you’re attending, I’d love to catch up and explore how we can work together.
#ERLIG2024 #DrugDiscovery #Pharmidex #Collaborations #Innovation
We’re pleased to share that Mo Yaqoob from our Business Development team will be attending the C3 Summit on 8 May 2025 at 8 Northumberland Ave, London. 🔗 https://www.thec3summit.com/london-2025/  Mo is looking forward to meeting fellow attendees, exploring new partnerships, and discussing how we can work together to accelerate the development of innovative drug candidates. If you're attending, don’t hesitate to connect let’s spark the next great collaboration!
We’re excited to share that Ash Alavijeh , our Head of Operations, will attend the Swiss Biotech Day 2025 on May 5–6 at the Congress Center Basel, Switzerland! 🔗 https://swissbiotechday.ch Ash looks forward to connecting with attendees to explore new collaborations and drive drug discovery and development forward. If you're in Basel, let's meet and discuss how we can advance the next wave of innovative therapies together.
We are pleased to announce that Martin Barrett , our Head of Business Development, will be attending the Making & Distributing Pharmaceuticals UK event on 29–30 April 2025 at the Coventry Building Society Arena! 🔗 ( https://lnkd.in/gd73pvE ) Martin would be delighted to meet with fellow attendees to discuss new collaboration opportunities and how we can work together to advance the development of innovative drug candidates. If you are attending, don’t miss the chance to connect with us and explore how we can drive pharmaceutical progress forward together!
